Updated Real-World Data Confirm the Effectiveness of Avelumab in First-Line Maintenance Treatment of Advanced Urothelial Carcinoma
Philippe Barthélémy discusses in this MEDtalk from ESMO 2024 the updated results from the AVENANCE trial. They confirm the effectiveness of avelumab first line maintenance in a real-world population.